Krka Reports Consolidated Earnings Results for the Year 2015; Provides Earnings Guidance for the Year 2016
March 03, 2016 at 06:54 am EST
Share
Krka reported consolidated earnings results for the year 2015. For the year, the company reported consolidated net profit fell 4.8% to €158.2 million ($172.1 million) in 2015. Consolidated sales edged down 2% to €1.16 billion last year.
The Group expects its net profit to rise to €160 million in 2016 on sales of €1.21 billion.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
